We are happy to announce the launch of NecstGen’s first development laboratory at the Leiden Bio Science Park.

Here, our scientists and analytical experts have started the first process development projects, supporting our clients to bring cell- and viral vector-based therapies to patients. This is another step towards realising NecstGen’s mission to accelerate the development of breakthrough cell and gene therapies.

Meanwhile, NecstGen is well underway in the establishment of its GMP facility at Mirai House, which is expected to open its doors in 2022.